Mode
Text Size
Log in / Sign up

Computational neuroimaging study finds tDCS anxiety reduction linked to specific fMRI connectivity patterns in older adults

Computational neuroimaging study finds tDCS anxiety reduction linked to specific fMRI connectivity p…
Photo by razi pouri / Unsplash
Key Takeaway
Recognize that tDCS efficacy varies by subtype, with only two of four clusters showing anxiety reduction.

This primary study abstract investigates the relationship between transcranial direct-current stimulation (tDCS) response and anxiety reduction in older adults at risk for Alzheimer's disease. The intervention involved tDCS combined with resting-state functional magnetic resonance imaging (fMRI). The authors utilized a BETA pipeline to analyze neural circuitry coupling and functional connectivity subtypes within this specific population.

Four distinct subtypes were identified through this computational approach. Two clusters demonstrated significant anxiety reduction following stimulation, while one cluster was resistant to frontal-lobe tDCS. Responsive subtypes were defined by strengthened connectivity between the lateral occipital cortex-superior division (sLOC) and medial frontal cortex (MedFC), as well as between sLOC and intracalcarine cortex (ICC). These patterns suggest specific neural mechanisms may predict treatment response.

The evidence has notable limitations. The publication type is an abstract, and specific metrics such as sample size, follow-up duration, p-values, and confidence intervals were not reported. The authors explicitly note that causality is not established, describing only an association between fMRI-based subtyping and tDCS response. Additionally, tDCS efficacy is not universal, as only two of four subtypes demonstrated significant anxiety reduction.

Despite these constraints, the findings provide a concrete roadmap for precision psychiatry in Alzheimer's disease and related dementias. The authors suggest this supports facilitating tailored therapeutic strategies for anxiety. Clinicians should interpret these results cautiously given the lack of statistical reporting and the preliminary nature of the abstract. Safety data regarding adverse events and tolerability were also not reported.

Study Details

EvidenceLevel 5
PublishedApr 2026
View Original Abstract ↓
Anxiety is usually gauged by self-report, yet a single symptom level can reflect disparate neural circuitry. In Alzheimer's disease and related dementias (ADRD) this heterogeneity becomes a barrier to effective neuromodulation: some patients may benefit from transcranial direct-current stimulation (tDCS), while others may not. To overcome this obstacle, we introduced BETA (Biotypes for tDCS Efficacy in Anxiety), a data-driven pipeline that uses resting-state fMRI functional connectivity to derive anxiety subtypes that are intrinsically linked to tDCS response. A transformer-based variational autoencoder compresses high-dimensional connectivity into a 50-dimensional latent embedding that emphasizes networks implicated in cognitive aging and anxiety. A deep-embedded clustering loss, regularized by a clinically informed term that pulls together individuals who exhibit similar post-tDCS anxiety change, yields four distinct subtypes. Across all subtypes, disrupted coupling between sensory-processing and higher-order cognitive regions emerges as a common hallmark. Crucially, one cluster is resistant to frontal-lobe tDCS, whereas two clusters demonstrate significant anxiety reduction following stimulation. The responsive subtypes are defined by strengthened connectivity between the lateral occipital cortex-superior division (sLOC) and medial frontal cortex (MedFC), and between sLOC and the intracalcarine cortex (ICC). BETA demonstrates that fMRI-based subtyping can directly identify which patients are likely to benefit from tDCS, providing a concrete roadmap for precision psychiatry in ADRD and facilitating tailored therapeutic strategies for anxiety.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.